Remedium Capital Partners, LLC
- SEC CIK
- 0002104501
- Latest filing
- Aug 7, 2026
Holdings in Q4 2025
Holdings as of Dec 31, 2025, filed Feb 12, 2026. Long positions only.
- Positions
- 6
- No filing for Q3 2025
- Portfolio value
- $170.2M
- No filing for Q3 2025
Remedium Capital Partners, LLC did not file a 13F for Q3 2025, so these holdings cannot be compared with the previous quarter and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SYRESpyre Therapeutics, Inc. | COM NEW | 1,456,231 | $47.7M | 28.0% | – | – | History |
| ORKAOruka Therapeutics, Inc. | COM | 1,552,414 | $47.1M | 27.6% | – | – | History |
| APGEApogee Therapeutics, Inc. | COM | 583,591 | $44.0M | 25.9% | – | – | History |
| JBIOJade Biosciences, Inc. | COM NEW | 1,577,750 | $24.3M | 14.3% | – | – | History |
| CBIOCrescent Biopharma, Inc. | COM | 361,250 | $4.28M | 2.5% | – | – | History |
| DMRADamora Therapeutics, Inc. | COM NEW | 120,473 | $2.77M | 1.6% | – | – | History |